Quarterly report · Q1

Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥4.9bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥20.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.9bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥76m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥132m2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥81m2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥1.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥223m2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥74m2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥222m2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥6m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥569m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥78m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥9m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥125m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥16.7bnat 2023-06-30Cons.Assets
Total assets¥16.5bnat 2023-03-31Cons.Assets
Total assets¥16.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.9bnat 2023-06-30Cons.Liabilities
Total liabilities¥5.6bnat 2023-03-31Cons.Liabilities
Net assets / equity¥10.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥10.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥10.4bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥3.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥3.7bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥1.722023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥170.532022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.352022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio63.2%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio64.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥18m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥18m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥855,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30¥12m
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥1.9bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥1.9bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥62m
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥2.7bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥2.7bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥108m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥431m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥265m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥166m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentsegment profit2023-04-01 → 2023-06-30−¥4m
—segment totalrevenue2023-04-01 → 2023-06-30¥5.1bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥4.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥166m
—segment totalsegment profit2023-04-01 → 2023-06-30¥166m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥167m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥178m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥22m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥846,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥15m
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥200m
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥78m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥376m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥233m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥143m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentsegment profit2022-04-01 → 2022-06-30−¥3m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.0bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥143m
—segment totalsegment profit2022-04-01 → 2022-06-30¥275m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥144m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥290m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 376
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant885400
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant885400
Shareholding ratio treasury shares etcCurrentQuarterInstant0.2100
Cash and depositsPrior1YearInstant3664081000JPY
Cash and depositsCurrentQuarterInstant3809970000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant2947145000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant2902502000JPY
Merchandise and finished goodsPrior1YearInstant431748000JPY
Merchandise and finished goodsCurrentQuarterInstant612628000JPY
Work in processPrior1YearInstant20215000JPY
Work in processCurrentQuarterInstant19991000JPY
Raw materials and suppliesPrior1YearInstant62760000JPY
Raw materials and suppliesCurrentQuarterInstant60904000JPY
Other caPrior1YearInstant208453000JPY
Other caCurrentQuarterInstant132002000JPY
Allowance for doubtful accounts caPrior1YearInstant-23519000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-20586000JPY
Current assetsPrior1YearInstant7310885000JPY
Current assetsCurrentQuarterInstant7517414000JPY
Buildings and structuresPrior1YearInstant4442450000JPY
Buildings and structuresCurrentQuarterInstant4415371000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-992174000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-1007256000JPY
Buildings and structures netPrior1YearInstant3450275000JPY
Buildings and structures netCurrentQuarterInstant3408115000JPY
Machinery equipment and vehiclesPrior1YearInstant24659000JPY
Machinery equipment and vehiclesCurrentQuarterInstant24659000JPY
Accumulated depreciation machinery equipment and vehiclesPrior1YearInstant-21776000JPY
Accumulated depreciation machinery equipment and vehiclesCurrentQuarterInstant-22040000JPY
Machinery equipment and vehicles netPrior1YearInstant2883000JPY
Machinery equipment and vehicles netCurrentQuarterInstant2619000JPY
Tools furniture and fixturesPrior1YearInstant2394117000JPY
Tools furniture and fixturesCurrentQuarterInstant2409139000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant-1867410000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant-1879445000JPY
Tools furniture and fixtures netPrior1YearInstant526706000JPY
Tools furniture and fixtures netCurrentQuarterInstant529693000JPY
LandPrior1YearInstant3429506000JPY
LandCurrentQuarterInstant3396831000JPY
Lease assets ppePrior1YearInstant782266000JPY
Lease assets ppeCurrentQuarterInstant782266000JPY
Accumulated depreciation lease assets ppePrior1YearInstant-160606000JPY
Accumulated depreciation lease assets ppeCurrentQuarterInstant-189325000JPY
Lease assets net ppePrior1YearInstant621660000JPY
Lease assets net ppeCurrentQuarterInstant592940000JPY
Construction in progressPrior1YearInstant417978000JPY
Construction in progressCurrentQuarterInstant443363000JPY
Property plant and equipmentPrior1YearInstant8449010000JPY
Property plant and equipmentCurrentQuarterInstant8373564000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass